Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New AAV gene therapy for mucopolysaccharidosis IVA

Sep. 6, 2019

Optimized liver-directed gene therapy for Pompe's disease evaluated in vivo

Sep. 5, 2019

CRISPR targets fat cells, improves metabolism

Sep. 5, 2019

Evaluation of the effects of atractylenolide I in a new mouse model of cancer cachexia

Sep. 5, 2019

Boehringer Ingelheim to advance BI-456906 into phase II for obesity and diabetes

Sep. 3, 2019

FDA approves Kuros' IND for phase IIa trial of KUR-113 for spinal fusion

Sep. 3, 2019

ObsEva reports mechanism-of-action data on oxytocin receptor antagonist nolasiban

Sep. 3, 2019

Crinetics Pharmaceuticals identifies somatostatin SST5 receptor agonists

Sep. 3, 2019

Novel organoid models cover a wide range of endometrial diseases

Sep. 2, 2019

Esperion reports phase II topline results for bempedoic acid/ezetimibe combination tablet

Aug. 30, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...